Aliases & Classifications for Filariasis

About this section

Aliases & Descriptions for Filariasis:

Name: Filariasis 10 47 12 36 65
 
Disease Due to Superfamily Filarioidea 10

Classifications:



External Ids:

Disease Ontology10 DOID:1080
ICD9CM29 125.9
MeSH36 D005368
NCIt42 C34611
UMLS65 C0016085

Summaries for Filariasis

About this section
Disease Ontology:10 A parasitic helminthiasis infectious disease that involves parasitic infection of the lymphatics and subcutaneous tissue by nematodes of the superfamily Filarioidea.

MalaCards based summary: Filariasis, also known as disease due to superfamily filarioidea, is related to chagas disease and b cell deficiency, and has symptoms including discharge from eye An important gene associated with Filariasis is IL5 (Interleukin 5), and among its related pathways are Inflammatory Response Pathway and Transcription_Role of VDR in regulation of genes involved in osteoporosis. Affiliated tissues include breast, liver and skin, and related mouse phenotypes are integument and tumorigenesis.

Wikipedia:68 Filariasis (or philariasis) is a parasitic disease caused by an infection with roundworms of the... more...

Related Diseases for Filariasis

About this section

Diseases related to Filariasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 283)
idRelated DiseaseScoreTop Affiliating Genes
1chagas disease30.3TLR4, TNF
2b cell deficiency29.5IFNG, IL10, IL2, TNF
3trachoma29.1IL10, IL6, TLR2, TLR4, TNF
4rheumatoid arthritis27.8CTLA4, IFNG, IL10, IL2, IL6, TLR2
5malaria26.5CHIT1, IFNG, IL10, IL2, IL5, IL6
6filarial elephantiasis11.9
7loiasis11.7
8dirofilariasis10.9
9onchocerciasis10.8
10lymph node cancer10.8TLR2, TLR4
11bartonellosis10.7TLR2, TLR4
12elephantiasis10.7
13protein r deficiency10.7TLR2, TLR4
14lymphedema10.6
15exophthalmos10.6CTLA4, TLR2, TLR4
16ureterocele10.6IL2, TNF
17eosinophilic granulomatosis with polyangiitis10.6IFNG, IL5
18mansonelliasis10.6
19punctate palmoplantar keratoderma type 210.6IL10, TNF
20autoimmune polyglandular syndrome type 210.6CTLA4, TNF
21cycloplegia10.5IFNG, IL10
22primary progressive freezing gait10.5IL10, TNF
23spinal polio10.5IFNG, IL2, TLR4
24anti-hla hyperimmunization10.5TLR2, TLR4, TNF
25balanitis10.5IL2, SRCIN1
26kearns-sayre syndrome10.5IL10, TNF
27auricular cancer10.5TLR2, TLR4, TNF
28ileocolitis10.5TLR2, TLR4, TNF
29autoimmune oophoritis10.5IFNG, TNF
30multifocal lymphangioendotheliomatosis with thrombocytopenia10.5IL10, TNF
31limbic encephalitis with ncmags antibodies10.5IFNG, IL2, IL5
32common cold10.5TLR2, TLR4, TNF
33thrombocytopenia due to platelet alloimmunization10.5IL2, TLR2, TNF
34anotia10.4IL2, IL6
35glomangiomatosis10.4IL10, IL6
36alcoholic gastritis10.4IL6, TLR2, TLR4
37plasmacytoma10.4IL2, IL6
38cholesteatoma of attic10.4IFNG, IL5
39brucella melitensis brucellosis10.4IL2, TNF
40graft-versus-host disease, protection against10.4IFNG, IL10, IL2
41podoconiosis10.4
42chronic demyelinizing neuropathy with igm monoclonal10.4IFNG, IL10, IL2
43louping ill10.4IFNG, IL10, IL2
44abdominal tuberculosis10.4IFNG, IL10, TLR2
45non-distal monosomy 10q10.4IFNG, TNF
46catamenial pneumothorax10.4IL10, IL6
47orbital plasma cell granuloma10.4IFNG, IL2, IL5
48alternating exotropia10.4IL10, TNF
49ethmoid sinus squamous cell carcinoma10.4IFNG, TNF
50aniseikonia10.4IL10, TLR2, TNF

Graphical network of the top 20 diseases related to Filariasis:



Diseases related to filariasis

Symptoms for Filariasis

About this section

UMLS symptoms related to Filariasis:


discharge from eye

Drugs & Therapeutics for Filariasis

About this section

Drugs for Filariasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 37)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
IvermectinapprovedPhase 4, Phase 3, Phase 24770288-86-76474909, 46936176
Synonyms:
(2aE,4E,5'S,6S,6'R,7S,8E,11R,13R,15S,17aR,20R,20aR,20bS)-20,20b-dihydroxy-5',6,8,19-tetramethyl-6'-[(1S)-1-methylpropyl]-17-oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b-tetradecahydro-2H,7H-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-3-O-methyl-alpha-L-arabino-hexopyranoside
22,23-Dihydroxy-avermectin B
22,23-Dihyroavermectin B1
5-O-Demethyl-22,23-dihydro-avermectin A1a
71827-03-7
AB00513813
AC1MJ4GR
AC1N7O27
BPBio1_000322
BRD-K24652731-001-02-7
BSPBio_000292
CHEMBL341047
CID11957587
CID4330618
CID6321424
CID6419971
CID6427057
EU-0100693
FT-0082656
HMS1568O14
HMS2089M09
I 8898
 
I8898_SIGMA
IVERMECTIN
Ivermectin
Ivermectina
Ivermectine
Ivermectinum
Lopac0_000693
MK-933
MLS001333247
MLS001333248
MLS002153248
MolPort-006-394-715
NCGC00094047-01
NCGC00094047-02
NCGC00094047-03
Prestwick2_000156
Prestwick3_000156
Prestwick_516
S1351_Selleck
SMR000857211
Sklice
Soolantra
Stromectol
2
PraziquantelapprovedPhase 43355268-74-14891
Synonyms:
(.+-)-2-(Cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro-4H-pyrazino(2,1a)isoquinolin-4-one
(11bS)-2-(cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one
135526-78-2
2-(Cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro- 4H-pyrazino[2,1-a]-isoquinolin-4-one
2-(Cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro-4H-pyrazino(2,1-a)isoquinolin-4-one
2-(Cyclohexylcarbonyl)-1,2,3,6,7-11b-hexahydro-4H-pyrazino(2,1a)isoquinolin-4-one
2-(Cyclohexylcarbonyl)-1,2,3,6,7-11b-hexahydro-4H-pyrazinoe(2,1a)isoquinolin-4-one
2-(cyclohexanecarbonyl)-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one
2-(cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one
2-Cyclohexanecarbonyl-1,2,3,6,7,11b-hexahydro-pyrazino[2,1-a]isoquinolin-4-one
2-Cyclohexylcarbonyl-1,2,3,6,7,11b-hexahydro-4H-pyrazino(2,1-a) isoquinolin-4-one
46648_FLUKA
46648_RIEDEL
5-24-03-00361 (Beilstein Handbook Reference)
55268-74-1
57452-31-0
8440, EMBAY
AB00052075
AC-11670
AC1L1J6N
AKOS000541869
Azinox
BAS 00347357
BPBio1_000088
BRD-A21858158-001-05-2
BRN 0761557
BSPBio_000080
BSPBio_002199
Bay-8440
Bayer Brand of Praziquantel
Biliricide
Biltricide
Biltricide (TN)
Biltricide, Droncit, Praziquantel
Bio-0456
C07367
CCRIS 4114
CHEMBL976
CID4891
CPD000037139
Cesol
Cisticid
Cutter
Cutter Tape Tabs
Cysticide
D00471
D011223
DB01058
DivK1c_000130
Droncit
Drontsit
EINECS 259-559-6
EINECS 260-741-2
EMBAY-8440
EU-0100909
Embay 8440
HMS1568D22
HMS1920J06
HMS2090J19
 
HMS2092A09
HMS500G12
I06-0088
IDI1_000130
InChI=1/C19H24N2O2/c22-18-13-20(19(23)15-7-2-1-3-8-15)12-17-16-9-5-4-6-14(16)10-11-21(17)18/h4-6,9,15,17H,1-3,7-8,10-13H
KBio1_000130
KBio2_001599
KBio2_004167
KBio2_006735
KBio3_001699
KBioGR_000963
KBioSS_001599
LS-23174
LS-7155
Lopac0_000909
MLS000028528
MLS000038419
MLS001201812
MLS001304085
Merck Brand of Praziquantel
MolPort-001-926-470
NCGC00015818-05
NCGC00015818-11
NCGC00089733-02
NCGC00089733-03
NCGC00089733-04
NCGC00089733-05
NINDS_000130
NPFAPI-02
Oprea1_163497
P 4668
P4668_SIGMA
Prasiquantel
Praziquantel (JAN/USP/INN)
Praziquantel [USAN:INN:BAN:JAN]
Praziquantel, (+-)-Isomer
Praziquantel, (R)-Isomer
Praziquantel, (S)-Isomer
Praziquantelum
Praziquantelum [INN-Latin]
Prestwick0_000260
Prestwick1_000260
Prestwick2_000260
Prestwick3_000260
Prestwick_402
Pyquiton
S1691_Selleck
SAM002264632
SMR000037139
SPBio_001295
SPBio_002299
SPECTRUM1500494
STK030186
Spectrum2_001288
Spectrum3_000550
Spectrum4_000482
Spectrum5_001064
Spectrum_001119
Traziquantel
UNII-6490C9U457
praziquantel
3
AzithromycinapprovedPhase 4, Phase 232283905-01-555185, 53477736, 447043
Synonyms:
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranoside
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranoside
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
1-Oxa-6-azacyclopentadecan-15-one, 13-((2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-,(2R-(2R*,3S*
121470-24-4
75199_FLUKA
83905-01-5
9-Deoxo-9a-aza-9a-methyl-9a-homoerythromycin A
AC-16014
AC1L9KEG
Aritromicina
Azasite
Azenil
Azifast
Azigram
Azimakrol
Azithramycine
Azithromycin
Azithromycin & Tumor Necrosis Factor
Azithromycin (AIDS Initiative)
Azithromycin (anhydrous)
Azithromycin Dihydrate
Azithromycin Monohydrate
Azithromycin Sterile
Azithromycin dihydrate
Azithromycin plus Tumor Necrosis Factor
Azithromycine
Azithromycine [French]
Azithromycinum
Azithromycinum [Latin]
Azitrocin
Azitromax
Azitromicina
Azitromicina [Spanish]
Azitromin
Azythromycin
BIDD:GT0792
BRN 5387583
BSPBio_002285
Bio-0676
C38H72N2O12
CCRIS 1961
CHEBI:2955
CHEMBL529
CID447043
CP-62993
CP62,993
CPD000471864
DCH3
DRG-0104
 
DivK1c_000233
HMS1922G12
HMS2094M11
HMS500L15
HSDB 7205
Hemomycin
IDI1_000233
KBio1_000233
KBio2_000787
KBio2_003355
KBio2_005923
KBio3_001505
KBioGR_000731
KBioSS_000787
LS-1834
MLS001055353
MLS001066331
MLS001201763
MLS001304005
MLS001332499
MLS001332500
Misultina
MolPort-002-507-426
N,N-Dimethyl-4-amino-benzaldehyde
NCGC00090753-01
NCGC00090753-02
NINDS_000233
NSC643732
SAM002589961
SMR000471864
SPBio_001544
SPECTRUM1503679
Spectrum2_001582
Spectrum3_000653
Spectrum4_000186
Spectrum5_001867
Spectrum_000307
Sumamed
Tromix
UNII-JTE4MNN1MD
XZ-450
Z-Pak
ZIT
Zentavion
Zithromac
Zithromax
Zithromax IV
Zithromycin
Zitromax
Zitromax Avium 600
Zmas
Zmax
azithromycin
4
AlbendazoleapprovedPhase 4, Phase 2, Phase 37254965-21-82082
Synonyms:
((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle
((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle [French]
(5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester
(5-Propylsulfanyl-1H-benzoimidazol-2-yl)-carbamic acid methyl ester
5-(Propylthio)-2-carbomethoxyaminobenzimidazole
54965-21-8
A4673_FLUKA
A4673_SIGMA
AB00052377
AC-015
AC1L1CVL
AC1Q2YKD
AKOS000540882
Albendazol
Albendazol [INN-Spanish]
Albendazole
Albendazole (JAN/USP/INN)
Albendazole Armstrong Brand
Albendazole Diba Brand
Albendazole Fustery Brand
Albendazole Hormona Brand
Albendazole Liferpal Brand
Albendazole Monohydrochloride
Albendazole Noe-Socopharm Brand
Albendazole Pfizer Brand
Albendazole Sanicoopa Brand
Albendazole Valdecasas Brand
Albendazole [USAN:INN:BAN:JAN]
Albendazolum
Albendazolum [INN-Latin]
Albendoral
Albenza
Albenza (TN)
Albenza, Eskazole, Zentel, Andazol, Albendazole
Armstrong Brand of Albendazole
BAS 00439961
BB_SC-1386
BIDD:GT0615
BIM-0051849.0001
BPBio1_000038
BRD-K79131256-001-04-7
BSPBio_000034
BSPBio_002548
Bendapar
Bilutac
C01779
CARBAMIC ACID, (5-(PROPYLTHIO)-1H-BENZIMIDAZOL-2-YL)-, METHYL ESTER
CAS-54965-21-8
CHEBI:16664
CHEBI:506787
CHEMBL1483
CID2082
CPD000036735
Carbamic acid, [5-(propylthio)-1H-benzimidazol-2-yl]-, methyl ester
ChemDiv1_000190
ChemDivAM_000003
D00134
D015766
DB00518
Diba Brand of Albendazole
Digezanol
Disthelm
Disthelm, Mediamix V
DivK1c_000704
EINECS 259-414-7
Endoplus
Eskazole
Fustery Brand of Albendazole
Gascop
HMS1568B16
HMS1922K04
HMS2090G19
HMS2093K13
HMS502D06
HMS587I14
HSDB 7444
Hormona Brand of Albendazole
I01-0380
IDI1_000704
InChI=1/C12H15N3O2S/c1-3-6-18-8-4-5-9-10(7-8)14-11(13-9)15-12(16)17-2/h4-5,7H,3,6H2,1-2H3,(H2,13,14,15,16)
KBio1_000704
 
KBio2_002012
KBio2_004580
KBio2_007148
KBioGR_000801
KBioSS_002012
LS-50618
Liferpal Brand of Albendazole
Lurdex
MLS000069722
Mediamix V Disthelm
Methyl 5-(propyl-thio)-2-benzimidazolecarbamate
Methyl 5-(propylthio)-2-benzimidazolecarbamate
Methyl [5-(Propylthio)benzimidazol-2-yl]carbamate
Methyl-5-[propylthio]-2-benzimidazole carbamate
Metiazol
MolPort-000-726-929
MolPort-000-760-571
MolPort-001-932-918
Monohydrochloride, Albendazole
NCGC00016876-01
NCGC00016876-02
NCGC00022896-03
NCGC00022896-04
NCGC00022896-05
NCGC00022896-06
NCGC00022896-07
NINDS_000704
NSC 220008
NSC220008
Noe Socopharm Brand of Albendazole
Noe-Socopharm Brand of Albendazole
O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate
Oprea1_429292
Oprea1_585016
Oprea1_640007
Pfizer Brand of Albendazole
Prestwick0_000247
Prestwick1_000247
Prestwick2_000247
Prestwick3_000247
Prestwick_675
Proftril
Ricobendazole
Rycobendazole
S1640_Selleck
SAM002589939
SK&F 62979
SK&F-62979
SK&F62979
SKF 62979
SKF-62979
SKF62979
SMR000036735
SPBio_002253
SPECTRUM1503903
STK387550
STL046130
STOCK2S-67946
Sanicoopa Brand of Albendazole
Smith Kline & French Brand of Albendazole
SmithKline Beecham Brand of Albendazole
Spectrum4_000201
Spectrum5_001567
Spectrum_001532
TL8003543
UNII-F4216019LN
V Disthelm, Mediamix
VU0239747-6
Valbazen
Valdecasas Brand of Albendazole
ZINC17146904
Zental
Zentel
[5-(Propylthio)benzimidazol-2-yl]carbamic Acid Methyl Ester
[5-(Propythio)-1H-benzimidazol-2-yl]carbamic acid methyl ester
albendazole
methyl N-(6-propylsulfanyl-1H-benzimidazol-2-yl)carbamate
methyl N-[6-(propylsulfanyl)-1H-1,3-benzodiazol-2-yl]carbamate
methyl [(2Z)-5-(propylsulfanyl)-1,3-dihydro-2H-benzimidazol-2-ylidene]carbamate
methyl [5-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate
methyl [5-(propylthio)-1H-benzimidazol-2-yl]carbamate
methyl [6-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate
5
DiethylcarbamazineapprovedPhase 4, Phase 21190-89-13052
Synonyms:
1-Diethylcarbamyl-4-methylpiperazine
12672-34-3
1642-54-2 (citrate (1:1))
4-23-00-00225 (Beilstein Handbook Reference)
5348-97-0
5348-97-0 (mono-hydrochloride)
8028-18-0
84L
90-89-1
AB00053457
AC1L1F2E
AI3-19612
AKOS003268016
BPBio1_000208
BRD-K45542189-048-05-6
BRN 0143029
BSPBio_000188
BSPBio_002179
Bitirazine
C07968
CHEMBL684
CID3052
Camin
Camin (TN)
Caracide
Carbamazine
Carbilazine
Caricide
Cypip
D07825
DB00711
Decacide
Diaethylcarbamazinum
Diethyl carbamazine
Diethylcarbamazin
Diethylcarbamazine (INN)
Diethylcarbamazine Citrate
Diethylcarbamazine [INN:BAN]
Diethylcarbamazinum
Diethylcarbamazinum [INN-Latin]
 
Dietilcarbamazina
Dietilcarbamazina [INN-Spanish]
Ditrazine Base
Ditrazine base
DivK1c_000548
Diéthylcarbamazine
EINECS 202-023-3
Ethodryl
FR-1031
IDI1_000548
KBio1_000548
KBio2_001418
KBio2_003986
KBio2_006554
KBio3_001399
KBioGR_001081
KBioSS_001418
LS-110688
Luxuran
MolPort-001-788-448
N,N-Diethyl-4-methyl-1-piperazinecarboxamide
N,N-diethyl-4-methylpiperazine-1-carboxamide
NCGC00178778-01
NCGC00178778-02
NINDS_000548
NSC1364
Notezine
Prestwick0_000284
Prestwick1_000284
Prestwick2_000284
Prestwick3_000284
SPBio_001203
SPBio_002407
Spatonin
Spectrum2_001022
Spectrum3_000390
Spectrum4_000511
Spectrum5_000877
Spectrum_000938
UNII-V867Q8X3ZD
diethylcarbamazine
6
Doxycyclineapproved, investigationalPhase 4, Phase 2219564-25-054671203, 5281011
Synonyms:
(2E,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6R)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(4S,4AR,5S,5ar,6R,12as)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
(4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
10597-92-9
17086-28-1 (mono-hydrate)
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6R,12aS)
24390-14-5
41411-66-9 (6-epimer, mono-hydrochloride)
5-Hydroxy-alpha-6-deoxytetracycline
564-25-0
6-Deoxyoxytetracycline
6-Deoxytetracycline
6-alpha-Deoxy-5-oxytetracycline
6-alpha-deoxy-5-oxytetracycline
69935-17-7 (mono-hydrochloride, di-hydrate)
6alpha-Deoxy-5-oxytetracycline
6α-deoxy-5-oxytetracycline
7164-70-7
7264-10-0
94088-85-4 (calcium salt (1:2))
AB08 (*Fosfatex)
AC1NQXW7
AC1NS4CW
AC1NUYS8
AC1O8PYM
Adoxa
Alodox
Alti-Doxycycline
Apo-Doxy
Atridox
Azudoxat
BCBcMAP01_000024
BIDD:GT0146
BMY-28689
BPBio1_000951
BSPBio_000863
BSPBio_001936
BU-3839T
C06973
CHEBI:50845
CHEMBL1433
CID5281011
CID5353597
CID5463943
CID6713981
CPD001550033
D07876
DB00254
DMSC (*Fosfatex)
DOXCYCLINE ANHYDROUS
DOXY
DOXYCYCLINE CALCIUM
DOXYCYCLINE MONOHYDRATE
Deoxymykoin
DivK1c_000345
Doryx
Dossiciclina
Dossiciclina [DCIT]
Doxcycline anhydrous
Doxiciclina
Doxiciclina [INN-Spanish]
Doxiciclina [Italian]
Doxitard
Doxivetin
Doxy 100
Doxy-Caps
Doxy-Puren
Doxy-Tabs
Doxycen
Doxychel
Doxychel (TN)
Doxycin
Doxycyclin
Doxycycline
Doxycycline (200mg/day) or Placebo
Doxycycline (INN)
 
Doxycycline (TN)
Doxycycline (anhydrous)
Doxycycline (internal use)
Doxycycline Hyclate
Doxycycline Monohydrate
Doxycycline anhydrous
Doxycycline hyclate
Doxycycline hydrochloride
Doxycycline-Chinoin
Doxycyclinum
Doxycyclinum [INN-Latin]
Doxysol
Doxytec
Doxytetracycline
EINECS 209-271-1
GS-3065 (*monohydrate)
HMS2090E06
HSDB 3071
Hydramycin
IDI1_000345
Investin
Jenacyclin
KBio1_000345
KBio2_001287
KBio2_003855
KBio2_006423
KBio3_001156
KBioGR_001133
KBioSS_001287
LS-187766
LS-93868
Liviatin
Lopac0_000405
MolPort-002-507-423
Monodox
Monodox (*monohydrate)
Morgidox
NCGC00161602-01
NCGC00161602-03
NCGC00161602-04
NCGC00167961-01
NCGC00179395-01
NINDS_000345
NSC633557
Novo-Doxylin
Nu-Doxycycline
Ocudox
Oracea
Prestwick0_000852
Prestwick1_000852
Prestwick2_000852
Prestwick3_000852
Ronaxan
SAM002589932
SMP1_000107
SPBio_000246
SPBio_002784
STOCK1N-34341
Spanor
Spectrum2_000143
Spectrum3_000408
Spectrum4_000527
Spectrum5_000947
Spectrum_000807
Supracyclin
UNII-334895S862
UPCMLD-DP021
UPCMLD-DP021:001
Vibra-tabs
Vibramycin
Vibramycin (*monohydrate)
Vibramycin Monohydrate
Vibramycin Novum
Vibramycine
Vibravenos
Vivox (*Hyclate)
alpha-6-Deoxy-5-hydroxytetracycline
alpha-6-Deoxyoxytetracycline
alpha-Doxycycline
doxycycline
7Antiparasitic AgentsPhase 4, Phase 3, Phase 21854
8Anti-Bacterial AgentsPhase 4, Phase 29140
9AnthelminticsPhase 4, Phase 3, Phase 2, Phase 1379
10AntimalarialsPhase 4, Phase 21058
11Anti-Infective AgentsPhase 4, Phase 3, Phase 217220
12Antimitotic AgentsPhase 4, Phase 2, Phase 34296
13Antiprotozoal AgentsPhase 4, Phase 2, Phase 31730
14Tubulin ModulatorsPhase 4, Phase 2, Phase 34279
15MilbemycinPhase 3, Phase 26
16Contraceptives, OralPhase 3, Phase 23734
17VitaminsPhase 33857
18
RifampicinapprovedPhase 230313292-46-15458213, 5381226
Synonyms:
1-b]furan-21-yl acetate
13292-46-1
3-(((4-Methyl-1-piperazinyl)imino)-methyl)rifamycin
3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV
3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin sv
3-(4-Methylpiperazinyliminomethyl)-rifamycin SV
3-(4-Methylpiperazinyliminomethyl)rifamycin SV
3-([(4-Methyl-1-piperazinyl)imino]methyl)rifamycin SV
3-[(4-Methyl-1-piperazinyl)iminomethyl]rifamycin SV
3-[[(4-Methyl-1-piperazinyl)imino]-methyl]rifamycin
46713_FLUKA
46713_RIEDEL
62534-43-4
8-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV
8-(4-Methylpiperazinyliminomethyl) rifamycin SV
8-[[(4-Methyl-1-piperazinyl)imino[methyl]rifamycin
8-[[(4-Methyl-1-piperazinyl)imino]methyl]rifamycin sv
8-[[(4-Methylpiperazinyl)imino]methyl]rifamycin sv
83907_FLUKA
83907_SIGMA
8CI)
AZT + Rifampin
Abrifam
Archidyn
Arficin
Arzide
BA-41166E
BIDD:PXR0014
BPBio1_000561
BSPBio_000509
Ba 41166
Ba 41166/E
Benemicin
Benemycin
Bio-0621
C06688
C43H58N4O12
CAS-13292-46-1
CCRIS 551
CHEBI:28077
CHEBI:455936
CHEMBL180
CID5381226
CID5388984
CID5458213
CID5702112
CID6604339
CID6708473
CID6842115
CID6912767
CID6913622
CPD001906767
D00211
DB01045
DRG-0109
Dione 21-acetate
Dipicin
DivK1c_000550
Doloresum
EINECS 236-312-0
Eremfat
Famcin
Fenampicin
HMS1569J11
HMS1920P08
HMS2089F12
HMS2092G09
HMS501L12
HSDB 3181
KBio1_000550
KBio2_000919
KBio2_003487
KBio2_006055
KBio3_003018
KBioGR_001780
KBioSS_000919
L-5103
L-5103 Lepetit
LS-7689
MLS000028552
MLS001148237
MLS001333745
MolPort-000-767-051
MolPort-002-513-586
MolPort-003-666-281
MolPort-006-395-891
NCGC00016699-01
NCGC00017365-01
NCGC00018178-01
NCGC00022678-03
NCGC00022678-04
NCGC00022678-05
NCGC00160500-01
 
NCI60_000309
NINDS_000550
NSC 113926
NSC-113926
NSC113926
Piperine & Rifampicin
Prestwick0_000525
Prestwick1_000525
Prestwick2_000525
Prestwick3_000525
Prestwick_833
R-Cin
R/AMP
R0079
R3501_SIAL
R3501_SIGMA
R5777_SIGMA
R7382_SIGMA
RAMP
RFP
RMP
Ramp
Reserpine & Rifampicin
Rf
Rfamipicin
Rifa
Rifadin
Rifadin (TN)
Rifadin I.V
Rifadin I.V.
Rifadin IV
Rifadin Iv
Rifadin, Rimactane, Rifampicin, Rifampin
Rifadine
Rifagen
Rifaldazin
Rifaldazine
Rifaldin
Rifam
Rifamicin AMP
Rifamor
Rifampicin
Rifampicin & EEP
Rifampicin & Propolis
Rifampicin (JP15/INN)
Rifampicin SV
Rifampicin [INN:BAN:JAN]
Rifampicin sodium
Rifampicina
Rifampicina [INN-Spanish]
Rifampicine
Rifampicine [French]
Rifampicinum
Rifampicinum [INN-Latin]
Rifampin
Rifampin (USP)
Rifampin [USAN]
Rifamsolin
Rifamycin
Rifamycin AMP
Rifamycin Amp
Rifaprodin
Rifcin
Rifinah
Rifobac
Rifoldin
Rifoldine
Riforal
Rimactan
Rimactane
Rimactane (TN)
Rimactazid
Rimactin
Rimactizid
Rimazid
Rimycin
Rofact
S1764_Selleck
SAM002264646
SMR000058322
SMR000653525
SPBio_002430
SPECTRUM1500529
STK080143
Sinerdol
Spectrum3_001837
Spectrum4_001250
Spectrum5_002018
Spectrum_000439
TNP00313
Tubocin
UNII-VJT6J7R4TR
WLN: V1 WQ A&1 E&1 E1UN- AT6N DNTJ D1
nchembio884-comp4
rifampin
19Nucleic Acid Synthesis InhibitorsPhase 23836
20Antitubercular AgentsPhase 21061
21Antibiotics, AntitubercularPhase 25971
22
DihydroartemisininPhase 28171939-50-96918483
Synonyms:
(3R,5aS,6R,8aS,9R,12R,12aR)-3,6,9-trimethyldecahydro-3,12-epoxypyrano[4,3-j][1,2]benzodioxepin-10-ol
1,5,9-trimethyl-(1R,4S,5R,8S,9R,10S,12R,13R)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-ol(Dihydroartemisinin)
71939-50-9
81496-81-3
AC-2067
AC1L32PY
AC1L9UV6
Ambotz71939-50-9
Artenimol
Artenimol (INN)
CHEBI:207229
CHEMBL25164
CID107770
 
CID456410
CID6918483
Cotecxin
D07362
D3793
Dihydroartemisinin
Dihydroartemisinine
Dihydroqinghaosu
Dihydroquinghaosu
Dihydroquinghoasu
GNF-PF-5634
JAV-110
LS-64240
VM3352
[3R-(3.alpha.,5a.beta.,6.beta.,8a.beta.,9.alpha.,10.alpha.,12.beta.,12aR*)]-Decahydro-10-hydroxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4.3-j]-1,2-benzodioxepin
23
PiperaquinePhase 2954085-31-85079497
Synonyms:
1,3-bis(1-(7-chloro-4'-quinolyl)-4'-piperazinyl)propane
1,3-bis(4-(7'-chloro-4'-quinoline)-1-piperazine)
4,4'-(propane-1,3-diyldipiperazine-4,1-diyl)bis(7-chloroquinoline)
4085-31-8
5-23-03-00072 (Beilstein Handbook Reference)
7-chloro-4-[4-[3-[4-(7-chloroquinolin-4-yl)piperazin-1-yl]propyl]piperazin-1-yl]quinoline
83764-65-2
AC1L3UA1
AC1Q3T7B
AR-1F7471
 
BRN 0905079
C29H32Cl2N6
CHEMBL303933
CID122262
FT-0082661
I06-1673
LS-142194
Piperaquinoline
Quinoline, 4,4'-(1,3-propanediyldi-4,1-piperazinediyl)bis(7-chloro- (9CI)
Quinoline, 4,4'-(1,3-propanediyldi-4,1-piperazinediyl)bis(7-chloro-)
ST51053186
piperaquine
24ArtemisininsPhase 2202
25ArtemisininePhase 2202
26ImmunoglobulinsPhase 24477
27AntibodiesPhase 24477
28Antibodies, MonoclonalPhase 22413
29Protein Kinase InhibitorsPhase 23162
30Imatinib MesylatePhase 2577123596
31
RomidepsinPhase 181128517-07-75352062
Synonyms:
(1S,4S,7Z,10S,16E,21R)-7-Ethylidene-4,21-bis(1-methylethyl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo(8.7.6)tricos-16-ene-3,6,9,19,22-pentone
(1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone
(1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetrazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone
128517-07-7
AC1NS1N3
Antibiotic FR 901228
C087123
C24H36N4O6S2
CHEBI:61080
CHEMBL343448
CID5352062
Chromadax
Chromadax (TN)
Cyclo((2Z)-2-amino-2-butenoyl-L-valyl-(3S,4E)-3-hydroxy-7-mercapto-4-heptenoyl-D-valyl-D-cysteinyl), cyclic (3?5)-disulfide"
D06637
FK 228
 
FK-228
FK-901228
FK228
FR 901228
FR-901228
FR901228
HDInhib_000006
Istodax
L-Valine, N-((3S,4E)-3-hydroxy-7-mercapto-1-oxo-4-heptenyl)-D-valyl-D-cysteinyl-(2Z)-2-amino-2-butenoxyl-, (4-1)-lactone, cyclic (1-2)-disulfide
LS-161318
NSC 630176
NSC-630176
NSC630176
Probes1_000153
Probes2_000337
Romidepsin
Romidepsin (USAN)
nchembio.313-comp2
32
Suraminapproved18145-63-15361
Synonyms:
1,3,5-Naphthalenetrisulfonic acid, 8,8'-[carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis- (9CI)
1,3,5-Naphthalenetrisulfonic acid, 8,8'-[carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-, hexasodium salt
1,3,5-Naphthalenetrisulfonic acid, 8,8'-[ureylenebis[m-phenylenecarbonylimino(4-methyl-m-phenylene)carbonylimino]]di- (8CI)
1,3,5-Naphthalenetrisulfonic acid, 8,8'-[ureylenebis[m-phenylenecarbonylimino(4-methyl-m-phenylene)carbonylimino]]di-, hexasodium salt
129-46-4 (hexa-hydrochloride salt)
145-63-1
3-14-00-02267 (Beilstein Handbook Reference)
8,8'-(Carbonylbis(imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino))bisnaphthalene-1,3,5-trisulphonic acid
8,8'-[CARBONYLBIS[IMINO-3,1-PHENYLENECARBONYLIMINO(4-METHYL-3,1-PHENYLENE)CARBONYLIMINO]]BIS-1,3,5-NAPHTHALENETRISULFONIC
8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid
8,8'-[Carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonyl-imino]]bis-1,3,5-naphthalenetrisulfonic acid
8,8'-[Carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonyl-imino]]bis-1,3,5-napthalenetrisulfonic acid
8,8'-[Ureylenebis[m-phenylenecarbonylimino(4-methyl-m-phenylene)carbonylimino]]di-1,3,5-naphthalenetrisulfonic acid
8,8'-[carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bisnaphthalene-1,3,5-trisulphonic acid
8-[[4-methyl-3-[[3-[[3-[[2-methyl-5-[(4,6,8-trisulfonaphthalen-1-yl)carbamoyl]phenyl]carbamoyl]phenyl]carbamoylamino]benzoyl]amino]benzoyl]amino]naphthalene-1,3,5-trisulfonic acid
AC1L1K6K
Antrypol
BRN 3230873
BSPBio_002248
Bayer 205
Belganyl
C07974
C51H40N6O23S6
CHEBI:45906
CHEMBL265502
CID5361
DB04786
DivK1c_006758
EINECS 205-658-4
Farma
Farma 939
Fourneau
Germanin
Harnstoff, symmetischer der 3-aminobenzoyl-3-amino-4-methylbenzoyl-1-naphthylamin-4,6,8-trisulfonsaeure
 
KBio1_001702
KBio2_002397
KBio2_004965
KBio2_007533
KBio3_001468
KBioGR_001774
KBioSS_002402
L000585
LS-95867
Lopac0_001182
Moranyl
NCGC00163318-01
NSC 34936
NSC34936
Naganil
Naganin
Naganine
Naganol
Naganol 6 Na
Naphuride
SGCTO-001
SURAMIN SODIUM
SVR
Sodium suramin
SpecPlus_000662
Spectrum3_000724
Spectrum4_001247
Spectrum_001877
Suramin
Suramin sodium
Suramine
Suramine sodium
WLN: L66J BSWQ DSWQ GSWQ JMVR D1 CMVR CMVMR CVMR B1 EVM-JL66J BSWQ DSWQ GSWQ &-NA-6
m,m'-Ureylen-bis-(8-(m-(benzamido)-p-toluamido)naphthalin-1,3,5-trisulfonsaeure)
suramin
sym-bis(m-aminobenzoyl-m-amino-p-methylbenzoyl-1-napthylamino-4,6,8-trisulfonate) carbamide
33
Mebendazoleapproved2231431-39-74030
Synonyms:
(5-Benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester
(5-Benzoyl-1H-benzimidazol-2-yl)carbamic acid methyl ester
(5-Benzoyl-1H-benzoimidazol-2-yl)-carbamic acid methyl ester
(5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester
2-Benzimidazolecarbamic acid, 5-benzoyl-, methyl ester
2-Benzimidazolecarbamic acid, 5-benzoyl-, methyl ester (8CI)
31431-39-7
46404_FLUKA
46404_RIEDEL
5-Benzoyl-2-benzimidazolecarbamic acid methyl ester
5-Benzoyl-2-benzimidazolecarbamic acid, methyl ester
AB00052203
AC-12064
AC1L1H98
AC1Q44DR
AKOS000539066
Abello Farmacia Brand of Mebendazole
Anti Worm
Anti-Worm
Ardeypharm Brand of Mebendazole
BAS 00341140
BIDD:GT0087
BPBio1_000257
BRD-K77987382-001-01-7
BRD-K77987382-001-06-6
BSPBio_000233
BSPBio_003178
Bantenol
Banworm
Besantin
Bio-0458
Bio-0803
Boots Brand of Mebendazole
Boots Threadworm Treatment
CAS-31431-39-7
CBDivE_010559
CCRIS 4479
CHEBI:6704
CHEMBL685
CID4030
CPD000036734
Carbamic acid, (5-benzoyl-1H-benzimidazol-2-yl)-, methyl ester
Carbamic acid, (5-benzoyl-1H-benzimidazol-2-yl)-, methyl ester (9CI)
Carbamic acid, N-(5-benzoylbenzimidazol-2-yl)-, methyl ester
D00368
D008463
DB00643
Degort's Brand of Mebendazole
Diba Brand of Mebendazole
DivK1c_000751
EINECS 250-635-4
Elfar Brand of Mebendazole
Equivurm Plus
Esteve Brand of Mebendazole
HMS1536H11
HMS1568L15
HMS1921F03
HMS2090B03
HMS2092B15
HMS502F13
HSDB 3232
Healthypharm Brand of Mebendazole
I06-2075
IDI1_000751
Janssen Brand of Mebendazole
KBio1_000751
KBio2_001778
KBio2_004346
KBio2_006914
KBio3_002398
KBioGR_000712
KBioSS_001778
LS-48951
Leidapharm Brand of Mebendazole
Lomper
M2523_FLUKA
M2523_SIGMA
MBDZ
MEBENDAZOLE, 99%
MLS000028491
Madicure
Mebendan
Mebendazol
Mebendazol [INN-Spanish]
Mebendazole
Mebendazole (JAN/USP)
 
Mebendazole (JAN/USP/INN)
Mebendazole [USAN:INN:BAN:JAN]
Mebendazole(USAN)
Mebendazolum
Mebendazolum [INN-Latin]
Mebenoazole
Mebenvet
Mebex
Mebutar
Methyl 5-benzoyl benzimidazole-2-carbamate
Methyl 5-benzoyl-2-benzimidazolecarbamate
Methyl 5-benzoyl-2-benzimidazolylcarbamate
Methyl N-(5-benzoyl-1H-benzimidazol-2-yl)carbamate
Methyl N-(5-benzoyl-2-benzimidazolyl)carbamate
MolPort-000-765-625
MolPort-001-889-615
Mébendazole
N-(Benzoyl-5, benzimidazolyl)-2, carbamate de methyle
N-(Benzoyl-5, benzimidazolyl)-2, carbamate de methyle [French]
N-2 (5-Benzoyl-benzimidazole) carbamate de methyle
N-2 (5-Benzoyl-benzimidazole) carbamate de methyle [French]
NCGC00016806-01
NCGC00016806-02
NCGC00021698-03
NCGC00021698-04
NCGC00021698-05
NCGC00021698-06
NINDS_000751
NSC 184849
NSC184849
Norgine Brand of Mebendazole
Noverme
Oprea1_278237
Oprea1_768530
Ovitelmin
Pantelmin
Pfizer Brand of Mebendazole
Prestwick0_000217
Prestwick1_000217
Prestwick2_000217
Prestwick3_000217
Prestwick_310
Pripsen Mebendazole
Probes1_000013
Probes2_000149
R 17,635
R 17635
R-17635
R17635
SAM002548959
SMR000036734
SPBio_001442
SPBio_002154
SPECTRUM1501110
SSL Brand of Mebendazole
STK093862
Spectrum2_001401
Spectrum3_001439
Spectrum4_000416
Spectrum5_001381
Spectrum_001298
Sqworm
Streger Brand of Mebendazole
Sufil
Surfont
TL8002405
Taxandria Brand of Mebendazole
Tedec Meiji Brand of Mebendazole
Telmin
TimTec1_000869
UNII-81G6I5V05I
Vermicidin
Vermicol
Vermidil
Vermin
Vermirax
Vermox
Vermox (TN)
Verpanyl
Versid
Wormkuur
ZINC00121541
mebendazole
methyl (5-benzoyl-1H-benzimidazol-2-yl)carbamate
methyl N-(6-benzoyl-1H-1,3-benzodiazol-2-yl)carbamate
methyl N-(6-benzoyl-1H-benzimidazol-2-yl)carbamate
methyl [5-(phenylcarbonyl)-1H-benzimidazol-2-yl]carbamate
34
Piperazineapproved22110-85-04837
Synonyms:
1,4-Diazacyclohexane
1,4-Diethylenediamine
1,4-Piperazine
110-85-0
14007-05-7 (unspecified hydrobromide)
142-63-2 (hexahydrate)
142-64-3 (di-hydrochloride)
14538-56-8 (phosphate[1:1])
16832-43-2 (unspecified hydrate)
1951-97-9 (unspecified phosphate)
3597-26-0 (unspecified sulfate)
5-23-01-00030 (Beilstein Handbook Reference)
6094-40-2 (unspecified hydrochloride)
7542-23-6 (mono-hydrochloride)
8017-90-1
8027-81-4
8057-14-5 (unspecified salt)
80621_FLUKA
854880-15-2
861800-35-3
AB1003720
AC1L1J2E
AC1Q1IA7
AC1Q1IA8
AC1Q1IA9
AKOS000269028
AR-1L1009
ARONIS23910
Anthalazine
Antiren
Asca-Trol No. 3
BIDD:GT0273
BRN 0102555
C07973
CCRIS 5950
CHEBI:28568
CHEMBL1412
CID4837
D00807
DB00592
Diethylenediamine
Diethyleneimine
Dispermine
DivK1c_000038
EINECS 203-808-3
Eraverm
Eraverm (VAN)
Fluphenazine dihydrochloride
HMS1920H20
HMS2092A03
HMS500B20
HSDB 1093
Hexahydro-1,4-diazine
Hexahydropyrazine
I14-11172
IDI1_000038
InChI=1/C4H10N2/c1-2-6-4-3-5-1/h5-6H,1-4H
Jsp000824
KBio1_000038
KBio2_001593
KBio2_004161
KBio2_006729
KBioSS_001593
LS-517
LTBB000432
Lumbrical
MolPort-000-872-010
NCGC00094762-01
NCGC00094762-02
NCIOpen2_000984
NCIOpen2_000988
NCIOpen2_001024
NCIOpen2_001031
NCIOpen2_001033
NCIOpen2_001071
NCIOpen2_001073
 
NCIOpen2_001111
NCIOpen2_001151
NCIOpen2_001231
NCIOpen2_001262
NCIOpen2_001269
NCIOpen2_004830
NCIOpen2_004834
NCIOpen2_004862
NCIOpen2_004874
NCIOpen2_004904
NCIOpen2_004910
NCIOpen2_004914
NCIOpen2_004942
NCIOpen2_004952
NCIOpen2_004954
NCIOpen2_004982
NCIOpen2_004992
NCIOpen2_004994
NCIOpen2_005022
NCIOpen2_005032
NCIOpen2_005034
NCIOpen2_005062
NCIOpen2_005072
NCIOpen2_005102
NCIOpen2_005108
NCIOpen2_005145
NCIOpen2_005182
NCIOpen2_005185
NCIOpen2_005187
NCIOpen2_005200
NCIOpen2_005575
NCIOpen2_005980
NCIOpen2_009422
NINDS_000038
NSC 474
NSC474
P0446
P0447
P45907_SIAL
PIPERAZINE (HEXAHYDRATE)
PZE
Piperazidine
Piperazin
Piperazin [German]
Piperazin [Germany]
Piperazine
Piperazine (USP)
Piperazine Dihydrochloride Dihydrochloride Hydrate
Piperazine Hexa-Hydrate
Piperazine [UN2579] [Corrosive]
Piperazine [UN2579] [Corrosive]
Piperazine [USAN]
Piperazine anhydrous
Piperazine citrate
Piperazine hexahydrate
Piperazine hydrate
Piperazine, anhydrous
Pipersol
Pyrazine hexahydride
Pyrazine, hexahy
SPECTRUM1500490
Spectrum5_001817
Spectrum_001113
UN2579
UNII-1RTM4PAL0V
Upixon
Uvilon
Vermex
Vermizine
Vermizine (TN)
Vermizine (tn)
WLN: T6M DMTJ
Worm-A-Ton
Worm-away
Wurmirazin
nchembio814-comp12
piperazine
piperazinium oleate
35Piperazine citrate22
36
Citric Acidnutraceutical100177-92-9311
Synonyms:
2-Hydroxy-1,2,3-propanetricarboxylate
2-Hydroxy-1,2,3-propanetricarboxylic acid
2-Hydroxytricarballylic acid
3-Carboxy-3-hydroxypentane-1,5-dioate
3-Carboxy-3-hydroxypentane-1,5-dioic acid
Aciletten
Anhydrous citrate
Anhydrous citric acid
Chemfill
Citraclean
 
Citrate
Citretten
Citric acid
Citro
Citronensäure
E 330
Hydrocerol A
Kyselina citronova
Suby G
Uro-trainer
beta-Hydroxytricarballylate
beta-Hydroxytricarballylic acid
37CitrateNutraceutical1001

Interventional clinical trials:

(show all 43)
idNameStatusNCT IDPhase
1Impact of Albendazole -Ivermectin on Wuchereria Bancrofti in MaliCompletedNCT02784743Phase 4
2Alternate Chemotherapy Regimens for the Clearance of W.Bancrofti InfectionCompletedNCT02005653Phase 4
3Post-Treatment Side Effects of Ivermectin or DEC for Loa Loa InfectionCompletedNCT01593722Phase 4
4Effect of Concomitant Mansonella Perstans Microfilaremia on Immune Responses Following Single Dose Praziquantel in People With SchistosomiasisRecruitingNCT02734186Phase 4
5Safety Study of Combined Azithromycin, Ivermectin and Albendazole for Trachoma and Lymphatic FilariasisWithdrawnNCT01903057Phase 4
6Study Comparing Moxidectin And Ivermectin In Subjects With Onchocerca Volvulus InfectionCompletedNCT00790998Phase 3
7Repeat Ivermectin Mass Drug Administrations for Control of Malaria: a Pilot Safety and Efficacy StudyActive, not recruitingNCT02509481Phase 2, Phase 3
8Efficacy of Ivermectin and Albendazole Against Onchocerciasis in the Volta Region, GhanaNot yet recruitingNCT02078024Phase 3
9Effect of Albendazole Dose on Treatment of Lymphatic FilariasisCompletedNCT00511004Phase 2
10Effect of Albendazole Dose on Clearance of Filarial WormsCompletedNCT00375583Phase 2
11Doxycycline to Treat Mansonella Perstans Infection in Patients With and Without Lymphatic FilariasisCompletedNCT00340691Phase 2
12Effect of Albendazole Dose on Clearance of Filarial WormsCompletedNCT00339417Phase 2
13Study Evaluating Orally Administered Moxidectin In Subjects With Onchocerca Volvulus InfectionCompletedNCT00300768Phase 2
14Clinical Trial of Rifampin and Azithromycin for the Treatment of River BlindnessCompletedNCT00127504Phase 2
15Eval 3-Drug Therapy Diethylcarbamize, Albendazole and Ivermectin That Could Accelerate LF Elimination Outside of AfricaRecruitingNCT01975441Phase 2
16Efficacy and Safety of High-dose Ivermectin for Reducing Malaria Transmission: A Dose Finding StudyRecruitingNCT02511353Phase 2
17Concomitant Infections of Mansonella Perstans in Tuberculosis and Buruli Ulcer Disease Patients From GhanaRecruitingNCT02281643Phase 2
18A Randomized, Placebo-controlled, Double-blind Pilot Study of Single-dose Humanized Anti-IL5 Antibody (Reslizumab) for the Reduction of Eosinophilia Following Diethylcarbamazine Treatment of Loa Loa InfectionActive, not recruitingNCT01111305Phase 2
19Efficacy and Microfilaricidal Kinetics of Imatinib for the Treatment of Loa LoaNot yet recruitingNCT02644525Phase 2
20Pediatric Pharmacokinetics And Safety Study Of MoxidectinWithdrawnNCT01035619Phase 2
21First in Man Clinical Trial of Emodepside (BAY 44-4400)RecruitingNCT02661178Phase 1
22Disability and Quality of Life in Patients With Lymphatic Filariasis in Rural Southern IndiaCompletedNCT01629771
23Interaction Between HIV and Lymphatic FilariasisCompletedNCT00295698
24Research for Elim of FilariasisCompletedNCT00145223
25Research for Elimination of Lymphatic Filariasis (ICIDR)CompletedNCT00406627
26Medical Implications of Coinfection With Malaria and Filariasis ParasitesCompletedNCT00471666
27Safety of the Co-administration of Three Drugs for Trachoma and Lymphatic Filariasis EliminationCompletedNCT01586169
28Evaluation of Antibacterial Soap for Treatment of Lymphedema in a Filariasis-Endemic AreaCompletedNCT00139100
29Changes in HIV Viral Load in Patients Undergoing Treatment for FilariasisCompletedNCT00344279
30Immune Response Regulation in People Infected Concurrently With Malarial and Filarial ParasitesCompletedNCT00341666
31Promoting Consistent Shoe Use Among Children At High Risk for PodoconiosisCompletedNCT01160523
32Safety and Efficacy of Drug Combinations Against Triple InfectionsCompletedNCT01050517
33Community Directed Treatment of Soil-Transmitted Helminths Among Young Children in ZambiaCompletedNCT00349323
34Study of Patients With Strongyloides Stercoralis InfectionCompletedNCT00001245
35Epidemiology and Control of Mansonella Perstans Infection in UgandaCompletedNCT00215280
36Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis for Ivory Coast (DOLF-Ivory Coast)RecruitingNCT02032043
37Exhaled NO Testing in FilariasisRecruitingNCT01628497
38Mass Drug Administration for Lymphatic Filariasis and Onchocerciasis for LiberiaRecruitingNCT01905436
39Effect of Filarial Infection on Immune Responses in Latent TuberculosisRecruitingNCT01547884
40Host Response to Infection and Treatment in Filarial DiseasesRecruitingNCT00001230
41Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and OnchocerciasisActive, not recruitingNCT01905423
42Genetic and Other Aspects of PodoconiosisNot yet recruitingNCT01939431
43Efficacy of Higher Albendazole and Ivermectin Doses on Wuchereria Bancrofti Microfilarial Clearance in MalawiTerminatedNCT01213576

Search NIH Clinical Center for Filariasis


Cochrane evidence based reviews: filariasis

Genetic Tests for Filariasis

About this section

Anatomical Context for Filariasis

About this section

MalaCards organs/tissues related to Filariasis:

33
Breast, Liver, Skin, Lung, Thyroid, Testes, B cells

Animal Models for Filariasis or affiliated genes

About this section

MGI Mouse Phenotypes related to Filariasis:

38 (show all 15)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00107718.6CTLA4, IFNG, IL10, IL6, TLR2, TLR4
2MP:00020068.4IFNG, IL10, IL2, IL5, IL6, TLR2
3MP:00053708.1CTLA4, IFNG, IL10, IL2, IL5, IL6
4MP:00053898.1IFNG, IL10, IL2, IL5, IL6, TLR4
5MP:00053678.0EDN1, IFNG, IL6, TLR2, TLR4, TLR9
6MP:00053888.0CTLA4, IFNG, IL10, IL2, IL5, IL6
7MP:00053697.9EDN1, IFNG, IL10, IL6, TLR2, TLR4
8MP:00053867.8IFNG, IL10, IL2, IL5, IL6, SRCIN1
9MP:00053797.8CTLA4, EDN1, IFNG, IL10, IL2, IL6
10MP:00053907.4CTLA4, EDN1, IFNG, IL10, IL6, TLR2
11MP:00053857.1CTLA4, EDN1, IFNG, IL10, IL2, IL6
12MP:00053816.5CTLA4, EDN1, IFNG, IL10, IL2, IL5
13MP:00053766.4CTLA4, EDN1, IFNG, IL10, IL2, IL5
14MP:00053975.8CTLA4, IFNG, IL10, IL2, IL5, IL6
15MP:00053875.7CHIT1, CTLA4, IFNG, IL10, IL2, IL5

Publications for Filariasis

About this section

Articles related to Filariasis:

(show top 50)    (show all 666)
idTitleAuthorsYear
1
Subcutaneous filariasis in India- Possible indication of human Dirofilariasis. (27004586)
2016
2
Minocycline as a re-purposed anti-Wolbachia macrofilaricide: superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasis. (26996237)
2016
3
Fly ash based Bacillus thuringiensis var. israelensis formulation for use against Culex quinquefasciatus, the vector of filariasis in natural ecosystems. (26418648)
2015
4
Synthesis and characterization of silver nanoparticles using Gmelina asiatica leaf extract against filariasis, dengue, and malaria vector mosquitoes. (25666372)
2015
5
Mapping of Bancroftian Filariasis in Cameroon: Prospects for Elimination. (26353087)
2015
6
Ongoing surveillance for lymphatic filariasis in togo: assessment of alternatives and nationwide reassessment of transmission status. (24189363)
2014
7
Evaluation of the Og34C filter paper technique in lymphatic filariasis prevalence studies. (25282872)
2014
8
Lymphatic filariasis: A view at pathological diversity. (25250237)
2014
9
Lymphatic filariasis control in Tanga Region, Tanzania: status after eight rounds of mass drug administration. (25387483)
2014
10
Evaluation of Brugia malayi sheath protein (Shp-1) as a diagnostic antigen for human lymphatic filariasis. (24389369)
2013
11
Will mass drug administration eliminate lymphatic filariasis? Evidence from northern coastal Tanzania. (23014581)
2013
12
Insights into the pathogenesis of disease in human lymphatic filariasis. (24044755)
2013
13
Therapeutic efficacy of poly (lactic-co-glycolic acid) nanoparticles encapsulated ivermectin (nano-ivermectin) against brugian filariasis in experimental rodent model. (24366812)
2013
14
Impact of three rounds of mass drug administration on lymphatic filariasis in areas previously treated for onchocerciasis in Sierra Leone. (23785535)
2013
15
Urban lymphatic filariasis in the city of Tanga, Tanzania, after seven rounds of mass drug administration. (24135628)
2013
16
Malaria and lymphatic filariasis: the case for integrated vector management. (23084831)
2013
17
Long-lasting insecticidal nets are synergistic with mass drug administration for interruption of lymphatic filariasis transmission in Nigeria. (24205421)
2013
18
Rapid assessment procedure for loiasis and mapping lymphatic filariasis: two perfect illustrations of "to be in English or not to be". (23272254)
2012
19
Larvicidal efficacy of Adhatoda vasica (L.) Nees against the bancroftian filariasis vector Culex quinquefasciatus Say and dengue vector Aedes aegypti L. in in vitro condition. (22167370)
2012
20
Cost-effective antigen testing for delimitation, monitoring and evaluation in bancroftian filariasis. (22290349)
2012
21
Studies on Fungal Cultural Filtrates against Adult Culex quinquefasciatus (Diptera: Culicidae) a Vector of Filariasis. (22132305)
2011
22
Epidemiological assessment of continuing transmission of lymphatic filariasis in Samoa. (22325816)
2011
23
Progress toward elimination of lymphatic filariasis--Togo, 2000--2009. (21796097)
2011
24
Application of the Filariasis CELISA Antifilarial IgG(4) Antibody Assay in Surveillance in Lymphatic Filariasis Elimination Programmes in the South Pacific. (21961018)
2011
25
The "filarial dance" is not characteristic of filariasis: observations of "dancing megasperm" on high-resolution sonography in patients from nonendemic areas mimicking the filarial dance and a proposed mechanism for this phenomenon. (21795491)
2011
26
Zoonotic Brugia pahangi filariasis in a suburbia of Kuala Lumpur City, Malaysia. (20951228)
2011
27
A rare case of reversible acquired AA-type renal amyloidosis in a chronic filariasis patient receiving antifilarial therapy. (21519822)
2011
28
Lymphatic filariasis. (21972476)
2011
29
Antigen detection assay with parasite specific monoclonal antibodies for diagnosis of lymphatic filariasis. (21741373)
2011
30
Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs. (21609260)
2011
31
The impact of a national program to eliminate lymphatic filariasis in selected Myanmar immigrant communities in Bangkok and Ranong Province, Thailand. (22299429)
2011
32
Cutaneous angiosarcoma in chronic lymphedema: secondary to filariasis. (23024552)
2011
33
Screening mosquito house entry points as a potential method for integrated control of endophagic filariasis, arbovirus and malaria vectors. (20689815)
2010
34
Geographic and ecologic heterogeneity in elimination thresholds for the major vector-borne helminthic disease, lymphatic filariasis. (20236528)
2010
35
Association between Toll-like receptor 2 (TLR2) polymorphisms and asymptomatic bancroftian filariasis. (20549240)
2010
36
The sharp end - experiences from the Tanzanian programme for the elimination of lymphatic filariasis: notes from the end of the road. (19843398)
2009
37
A pilot program of mass surgery weeks for treatment of hydrocele due to lymphatic filariasis in central Nigeria. (19270297)
2009
38
Ten years of managing the clinical manifestations and disabilities of lymphatic filariasis. (19843392)
2009
39
Nigeria's war on terror: fighting dracunculiasis, onchocerciasis, lymphatic filariasis, and schistosomiasis at the grassroots. (19407107)
2009
40
Global programme to eliminate lymphatic filariasis. (18788146)
2008
41
Impact of seven rounds of mass administration of diethylcarbamazine and ivermectin on prevalence of chronic lymphatic filariasis in south India. (18346027)
2008
42
An unusual presentation of filariasis: a case report. (18499995)
2008
43
Eliminating lymphatic filariasis: a view from the field. (18579875)
2008
44
Pharmacovigilance through consumer feedback (reporting) in the mass treatment of lymphatic filariasis using diethylcarbamazine and albendazole in two districts of Sri Lanka. (18631319)
2008
45
National mass drug administration costs for lymphatic filariasis elimination. (17989784)
2007
46
Confirmation of elimination of lymphatic filariasis by an IgG4 enzyme-linked immunosorbent assay with urine samples in Yongjia, Zhejiang Province and Gaoan, Jiangxi Province, People's Republic of China. (17690407)
2007
47
Epidemiological modelling for monitoring and evaluation of lymphatic filariasis control. (18063097)
2007
48
A critical appraisal of molecular xenomonitoring as a tool for assessing progress toward elimination of Lymphatic Filariasis. (17978055)
2007
49
Ocular filariasis due to Wuchereria bancrofti presenting as panuveitis: a case report. (14533034)
2003
50
Treatment of elephantiasis in a community with timorian filariasis. (3992641)
1985

Variations for Filariasis

About this section

Expression for genes affiliated with Filariasis

About this section
Search GEO for disease gene expression data for Filariasis.

Pathways for genes affiliated with Filariasis

About this section

Pathways related to Filariasis according to GeneCards Suite gene sharing:

(show top 50)    (show all 58)
idSuper pathwaysScoreTop Affiliating Genes
19.6IFNG, IL2, IL5
29.4IFNG, IL6, TNF
39.3IFNG, IL10, IL2, IL5
49.3IFNG, IL10, IL2, IL5
59.3IFNG, TLR2, TLR4, TNF
69.2IFNG, IL2, IL5, IL6
7
Show member pathways
9.2IFNG, IL10, IL2, TNF
89.2IL6, TLR2, TLR4, TNF
99.2IL6, TLR2, TLR4, TNF
109.2IFNG, IL10, IL2, IL6
119.1IL10, IL6, TLR4, TNF
129.1IL10, IL6, TLR4, TNF
13
Show member pathways
9.1IFNG, IL6, TLR4, TNF
149.1IFNG, IL2, IL6, TNF
15
Show member pathways
9.0TLR1, TLR2, TLR4, TLR6
16
Show member pathways
9.0IFNG, IL10, TLR2, TLR4, TNF
179.0IFNG, IL10, IL2, IL5, TNF
18
Show member pathways
8.9IFNG, IL10, IL2, IL5, IL6
19
Show member pathways
8.9CTLA4, IFNG, IL2, IL5, TNF
208.8IFNG, IL2, IL6, TLR4, TNF
21
Show member pathways
8.8IFNG, IL10, IL2, IL6, TNF
228.7EDN1, IFNG, IL6, TLR4
238.6IFNG, IL10, IL6, TLR2, TLR4, TNF
248.6IFNG, IL10, IL2, IL5, IL6, TNF
258.6IFNG, IL10, IL2, IL5, IL6, TNF
26
Show member pathways
8.6IFNG, IL10, IL2, IL5, IL6, TNF
278.5CTLA4, IFNG, IL6, TLR2, TLR4, TNF
288.5IFNG, IL10, IL6, TLR9, TNF
29
Show member pathways
8.4TLR1, TLR2, TLR4, TLR6, TLR9
308.4TLR1, TLR2, TLR4, TLR6, TLR9
31
Show member pathways
8.2CTLA4, IFNG, IL10, IL2, IL5, IL6
328.2IFNG, IL10, IL2, IL6, TLR9, TNF
33
Show member pathways
8.0TLR1, TLR2, TLR4, TLR6, TLR9, TNF
34
Show member pathways
8.0TLR1, TLR2, TLR4, TLR6, TLR9, TNF
357.9IFNG, IL10, IL6, TLR2, TLR4, TLR9
36
Show member pathways
7.9IFNG, IL2, IL6, TLR2, TLR4, TLR9
37
Show member pathways
7.8IL2, IL5, TLR1, TLR2, TLR4, TLR6
387.7CTLA4, IL10, IL5, IL6, TLR2, TLR4
39
Show member pathways
7.7CTLA4, IFNG, IL10, IL2, IL5, IL6
40
Show member pathways
7.6IFNG, IL6, TLR1, TLR2, TLR4, TLR6
41
Show member pathways
7.4IFNG, IL2, TLR1, TLR2, TLR4, TLR6
42
Show member pathways
7.3IL2, IL6, TLR1, TLR2, TLR4, TLR6
43
Show member pathways
7.2IFNG, IL6, TLR1, TLR2, TLR4, TLR6
447.2IFNG, IL6, TLR1, TLR2, TLR4, TLR6
457.0IFNG, IL10, IL6, TLR1, TLR2, TLR4
46
Show member pathways
6.8IL10, IL2, IL5, IL6, TLR1, TLR2
47
Show member pathways
6.7EDN1, IL6, TLR1, TLR2, TLR4, TLR6
48
Show member pathways
6.7IFNG, IL10, IL2, IL6, TLR1, TLR2
49
Show member pathways
6.7IFNG, IL10, IL2, IL6, TLR1, TLR2
50
Show member pathways
6.4CTLA4, IFNG, IL2, IL5, IL6, TLR1

GO Terms for genes affiliated with Filariasis

About this section

Cellular components related to Filariasis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1external side of plasma membraneGO:00098979.5CTLA4, IL6, TLR4

Biological processes related to Filariasis according to GeneCards Suite gene sharing:

(show top 50)    (show all 67)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of interleukin-12 biosynthetic processGO:004508410.6IFNG, TLR4
2positive regulation of interleukin-8 biosynthetic processGO:004541610.5TLR4, TNF
3receptor biosynthetic processGO:003280010.5IL10, TNF
4negative regulation of cytokine secretion involved in immune responseGO:000274010.5IL10, TNF
5neutrophil apoptotic processGO:000178110.5IFNG, IL6
6positive regulation of calcidiol 1-monooxygenase activityGO:006055910.5IFNG, TNF
7positive regulation of podosome assemblyGO:007180310.4IL5, TNF
8detection of diacyl bacterial lipopeptideGO:004249610.4TLR2, TLR6
9epithelial cell proliferation involved in salivary gland morphogenesisGO:006066410.4IL6, TNF
10positive regulation of isotype switching to IgG isotypesGO:004830410.4IFNG, IL2
11positive regulation of interleukin-18 productionGO:003274110.3TLR2, TLR9
12positive regulation of interferon-beta biosynthetic processGO:004535910.3TLR4, TLR9
13positive regulation of chemokine productionGO:003272210.3TLR2, TLR4, TNF
14cellular response to lipoteichoic acidGO:007122310.3TLR2, TLR4
15interleukin-1 beta secretionGO:005070210.2TLR4, TLR6
16cellular response to triacyl bacterial lipopeptideGO:007172710.2TLR1, TLR2
17cellular response to diacyl bacterial lipopeptideGO:007172610.1TLR2, TLR6
18defense response to protozoanGO:004283210.1IFNG, IL10, IL6
19negative regulation of growth of symbiont in hostGO:004413010.1IFNG, IL10, TNF
20positive regulation of MHC class II biosynthetic processGO:004534810.1IFNG, IL10, TLR4
21positive regulation of interferon-gamma productionGO:003272910.0IL2, TLR4, TNF
22positive regulation of interferon-beta productionGO:003272810.0TLR2, TLR4, TLR9
23defense response to Gram-positive bacteriumGO:005083010.0IL6, TLR2, TNF
24positive regulation of inflammatory responseGO:005072910.0IL2, TLR2, TLR4
25positive regulation of nitric-oxide synthase biosynthetic processGO:005177010.0TLR2, TLR4, TLR9
26I-kappaB phosphorylationGO:00072529.9TLR2, TLR4, TLR9
27response to bacteriumGO:00096179.9CHIT1, IL6, TLR4
28positive regulation of NF-kappaB import into nucleusGO:00423469.9TLR4, TLR9, TNF
29positive regulation of interleukin-6 biosynthetic processGO:00454109.9IFNG, TLR1, TLR6
30extrinsic apoptotic signaling pathwayGO:00971919.8IFNG, TLR4, TNF
31regulation of cytokine secretionGO:00507079.8TLR4, TLR6, TLR9
32positive regulation of interleukin-6 productionGO:00327559.7IL6, TLR4, TNF
33positive regulation of sequence-specific DNA binding transcription factor activityGO:00510919.7IL10, IL5, IL6, TNF
34positive regulation of interleukin-12 productionGO:00327359.6IFNG, TLR2, TLR4, TLR9
35positive regulation of tumor necrosis factor productionGO:00327609.6IFNG, TLR2, TLR4, TLR9
36defense response to Gram-negative bacteriumGO:00508299.5IL6, TLR4, TLR9
37toll-like receptor 4 signaling pathwayGO:00341429.5TLR1, TLR2, TLR4, TLR6
38positive regulation of nitric oxide biosynthetic processGO:00454299.5EDN1, IL6, TNF
39negative regulation of interleukin-6 productionGO:00327159.5IL10, TLR4, TLR9, TNF
40positive regulation of transcription, DNA-templatedGO:00458939.3IFNG, IL10, IL5, IL6, TNF
41positive regulation of smooth muscle cell proliferationGO:00486619.3EDN1, IL6, TNF
42cellular response to lipopolysaccharideGO:00712229.3IFNG, IL6, TLR4, TNF
43positive regulation of gene expressionGO:00106288.9IFNG, IL6, TLR4, TLR9
44toll-like receptor signaling pathwayGO:00022248.7TLR1, TLR2, TLR4, TLR6, TLR9
45MyD88-dependent toll-like receptor signaling pathwayGO:00027558.7TLR1, TLR2, TLR4, TLR6, TLR9
46inflammatory responseGO:00069548.4IL10, IL5, IL6, TLR1, TLR6, TNF
47defense response to bacteriumGO:00427428.3IFNG, IL10, TLR1, TLR4, TLR6, TNF
48positive regulation of JUN kinase activityGO:00435078.2EDN1, TLR6, TLR9, TNF
49immune responseGO:00069557.4CHIT1, IFNG, IL10, IL2, IL5, IL6
50positive regulation of transcription from RNA polymerase II promoterGO:00459447.4EDN1, IFNG, IL10, IL2, IL6, TLR4

Sources for Filariasis

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet